Chris J. van Boxtel

576 total citations
22 papers, 429 citations indexed

About

Chris J. van Boxtel is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Computational Theory and Mathematics. According to data from OpenAlex, Chris J. van Boxtel has authored 22 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Computational Theory and Mathematics. Recurrent topics in Chris J. van Boxtel's work include Computational Drug Discovery Methods (6 papers), Malaria Research and Control (6 papers) and Pharmaceutical studies and practices (4 papers). Chris J. van Boxtel is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Malaria Research and Control (6 papers) and Pharmaceutical studies and practices (4 papers). Chris J. van Boxtel collaborates with scholars based in Netherlands, Vietnam and Sweden. Chris J. van Boxtel's co-authors include B. Oosterhuis, Peter J. de Vries, Richard P. Koopmans, R J van Ketel, Jan Karel M. Eeftinck Schattenkerk, Jan de Gans, J. Stam, Peter Portegies, F.W.M. van der Wielen and Piet A. Kager and has published in prestigious journals such as Chemosphere, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

Chris J. van Boxtel

21 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris J. van Boxtel Netherlands 12 146 110 107 98 83 22 429
Eleanor D. Campbell United States 12 117 0.8× 44 0.4× 36 0.3× 29 0.3× 76 0.9× 21 540
R A Yeates Germany 16 67 0.5× 182 1.7× 251 2.3× 125 1.3× 21 0.3× 35 692
Trinh Kim Anh Vietnam 12 292 2.0× 138 1.3× 53 0.5× 74 0.8× 77 0.9× 18 459
Katarina Ilić United States 11 42 0.3× 119 1.1× 37 0.3× 132 1.3× 43 0.5× 25 435
Sam Liao United States 14 52 0.4× 134 1.2× 58 0.5× 92 0.9× 10 0.1× 27 695
Omobola A Ogundahunsi Nigeria 11 186 1.3× 25 0.2× 26 0.2× 58 0.6× 24 0.3× 20 358
ML Orme United Kingdom 13 279 1.9× 60 0.5× 73 0.7× 339 3.5× 35 0.4× 17 860
Heather Skor United States 12 97 0.7× 87 0.8× 94 0.9× 17 0.2× 19 0.2× 12 660
Lisa Pence United States 16 49 0.3× 63 0.6× 82 0.8× 143 1.5× 11 0.1× 28 570
Fatai A. Fehintola Nigeria 16 546 3.7× 59 0.5× 101 0.9× 147 1.5× 83 1.0× 66 811

Countries citing papers authored by Chris J. van Boxtel

Since Specialization
Citations

This map shows the geographic impact of Chris J. van Boxtel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris J. van Boxtel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris J. van Boxtel more than expected).

Fields of papers citing papers by Chris J. van Boxtel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris J. van Boxtel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris J. van Boxtel. The network helps show where Chris J. van Boxtel may publish in the future.

Co-authorship network of co-authors of Chris J. van Boxtel

This figure shows the co-authorship network connecting the top 25 collaborators of Chris J. van Boxtel. A scholar is included among the top collaborators of Chris J. van Boxtel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris J. van Boxtel. Chris J. van Boxtel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, John T. & Chris J. van Boxtel. (2015). Pharmacokinetics of Erythromycin in Man1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 25. 181–203. 3 indexed citations
2.
Boxtel, Chris J. van & I. Ralph Edwards. (2005). Lapdap™ and the Sunday Times – Britain. International Journal of Risk & Safety in Medicine. 17(3-4). 169–172. 2 indexed citations
3.
Wiegman, Albert, et al.. (2004). Steady-State Pharmacokinetics of Pravastatin in Children with Familial Hypercholesterolaemia. Clinical Drug Investigation. 24(2). 113–120. 3 indexed citations
4.
Escher, Johanna C., Karin Dilger, Dietmar Trenk, et al.. (2004). Pharmacokinetics of Mesalazine Pellets in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 10(5). 626–631. 14 indexed citations
5.
Boxtel, Chris J. van. (2004). Some safety aspects of generic prescribing. International Journal of Risk & Safety in Medicine. 16(3). 191–194. 1 indexed citations
6.
Boxtel, Chris J. van. (2004). Lessons still to be learned from thalidomide. International Journal of Risk & Safety in Medicine. 16(2). 103–106. 2 indexed citations
7.
Boxtel, Chris J. van. (2002). Cefditoren Pivoxil. Drugs. 62(2). 337–338.
8.
Koopmans, Richard P., et al.. (2000). Prevention by theophylline of beta-2-receptor down regulation in healthy subjects. European Journal of Drug Metabolism and Pharmacokinetics. 25(3-4). 179–188. 5 indexed citations
9.
Vries, Peter J. de, et al.. (1999). Declining Concentrations of Dihydroartemisinin in Plasma during 5-Day Oral Treatment with Artesunate for Falciparum Malaria. Antimicrobial Agents and Chemotherapy. 43(3). 690–692. 48 indexed citations
10.
Koopmans, Richard P., et al.. (1998). The pharmacokinetics of artemisinin suppositories in Vietnamese patients with malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(4). 434–436. 12 indexed citations
11.
12.
Vries, Peter J. de, et al.. (1997). The Pharmacokinetics of a Single Dose of Artemisinin in Patients with Uncomplicated Falciparum Malaria. American Journal of Tropical Medicine and Hygiene. 56(5). 503–507. 19 indexed citations
13.
Koopmans, Richard P., et al.. (1995). Pharmacokinetic-Pharmacodynamic Modelling As Applied to Bronchial Asthma. Clinical Pharmacokinetics. 29(4). 213–220. 3 indexed citations
14.
Vries, Peter J. de, et al.. (1994). The Pharmacokinetics of a Single Dose of Artemisinin in Healthy Vietnamese Subjects. American Journal of Tropical Medicine and Hygiene. 51(6). 785–790. 57 indexed citations
15.
Gans, Jan de, Peter Portegies, Jan Karel M. Eeftinck Schattenkerk, et al.. (1992). Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS. 6(2). 185–190. 94 indexed citations
16.
Jonkers, René E., et al.. (1992). Quantification of Theophylline-Induced Eosinopenia and Hypokalaemia in Healthy Volunteers. Clinical Pharmacokinetics. 22(3). 231–237. 7 indexed citations
17.
Koopmans, Richard P., Jasper Dingemanse, Meindert Danhof, G.P.M. Horsten, & Chris J. van Boxtel. (1991). The influence of dosage time of midazolam on its pharmacokinetics and effects in humans. Clinical Pharmacology & Therapeutics. 50(1). 16–24. 19 indexed citations
18.
Oosterhuis, B. & Chris J. van Boxtel. (1988). Kinetics of Drug Effects in Man. Therapeutic Drug Monitoring. 10(2). 121–132. 24 indexed citations
19.
Jonkers, René E., Chris J. van Boxtel, & B. Oosterhuis. (1987). Beta-2-adrenoceptor—mediated hypokalemia and its abolishment by oxprenolol. Clinical Pharmacology & Therapeutics. 42(6). 627–633. 22 indexed citations
20.
Oosterhuis, B., et al.. (1986). Pharmacokinetic-pharmacodynamic modeling of terbutaline bronchodilation in asthma. Clinical Pharmacology & Therapeutics. 40(4). 469–475. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleanor D. Campbell Breakdown of academic impact, for papers by R A Yeates Breakdown of academic impact, for papers by Trinh Kim Anh Breakdown of academic impact, for papers by Katarina Ilić Breakdown of academic impact, for papers by Sam Liao Breakdown of academic impact, for papers by Omobola A Ogundahunsi Breakdown of academic impact, for papers by ML Orme Breakdown of academic impact, for papers by Heather Skor Breakdown of academic impact, for papers by Lisa Pence Breakdown of academic impact, for papers by Fatai A. Fehintola
Rankless by CCL
2026